Ali Behbahani - 15 Jan 2024 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Stephanie Brecher, attorney-in-fact
Issuer symbol
ADAP
Transactions as of
15 Jan 2024
Net transactions value
$0
Form type
4
Filing time
17 Jan 2024, 17:06:47 UTC
Previous filing
21 Dec 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +40,950 $0.000000 40,950 15 Jan 2024 Ordinary Shares 40,950 $0.1400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.11 based on an exchange rate of U.S.$1.274570 to GBP1.00. The actual exercise price will be the pounds sterling amount.